MEDIA CENTRE    |    PRINT    |     FRANÇAIS
   

 
Tel.: 514-340-8222 ext. 24984
email address

Dr. Volker Blank
 
Senior Investigator, Lady Davis Institute
Associate Professor, Department of Medicine, McGill University
 
Dr. Blank's Publications Indexed on PubMed

Dr. Volker Blank received his doctorate from the University of Paris VI (Pierre & Marie Curie) and the Pasteur Institute in Paris. He did his postdoctoral training at Stanford University in Palo Alto, California and Harvard Medical School in Boston. Dr. Blank is currently an Associate Professor in the Department of Medicine at McGill University and a Project Director at the Lady Davis Institute, Jewish General Hospital. He is also an Associate Member of the Department of Physiology at McGill University.
 
Major Research Activities

Dr. Blank’s laboratory is interested in the functions of the CNC and small Maf basic-leucine zipper transcription factors. The research team he leads has the following objectives: 1) Analyze the molecular mechanisms that regulate the differentiation of erythroid cells, with particular emphasis on the p45 NF-E2 transcription factor; 2) Determine the role of the Nrf3 transcription factor in mammalian gene regulation; 3) Examine the regulation of the MafF protein in proinflammatory cytokine signaling. The long-term goal of these studies is to design novel treatment options for patients with erythroid cell disorders and cancer.

Recent Publications 
 
Kannan MB, Dodard-Friedman I & Blank V. Stringent control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) protein degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and glycogen synthase kinase 3 (GSK3). Journal of Biological Chemistry 2015, 290: 26292-302.

Gasiorek JJ, Mikhael M, Garcia-Santos D, Hui ST, Ponka P & Blank V. Thioredoxin-interacting protein regulates the differentiation of erythroid precursors. Experimental Hematology 2015, 43: 393-403.

Chevillard G, Paquet M & Blank V. Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma. Blood 2011, 117; 2005-2008.
Dr. Blank is an internationally recognized researcher in the fields of erythropoiesis and cancer.

He participated in the first cloning and analysis of NF-kappaB, a transcriptional regulator that plays a key role in immunity and infection.

He is known for his studies on CNC and Maf transcription factor family members that play important roles in mammalian differentiation, oncogenesis and stress response.
 


Dr. Blank’s website at the McGill University Division of Experimental Medicine

Dr. Blank’s website at the McGill University Department of Physiology


Copyright © 2010 Lady Davis Institute/Jewish General Hospital.
Created by Blue Lemon Media Inc.
Sitemap | Disclaimer